These terms get used interchangeably in coverage of psilocybin policy but they mean very different things. Can someone lay out clearly what each means in practice, what the current state of each is across the US, and what the realistic path is for each model going forward?
Reply #1 · ▲ 73 upvotes
Decriminalization means removing criminal penalties for personal possession and/or use — you typically can't be arrested or prosecuted, but the substance remains illegal, you can't buy or sell it legally, and civil penalties (fines) may still apply. This is the model in Denver (2019, first US city), Oakland, Santa Cruz, Somerville, and the 2020 Oregon Measure 110. Decriminalization protects individual users without creating a legal supply chain.
Reply #2 · ▲ 61 upvotes
Legalization creates a regulated legal framework — licensed production, distribution, and sale or service. Oregon Measure 109 and Colorado Prop 122 are legalization of licensed services, not full legalization for personal purchase. Full commercial legalization (like cannabis) doesn't currently exist for psilocybin anywhere in the US.
Reply #3 · ▲ 48 upvotes
The policy debate: harm reduction advocates often prefer decriminalization first because it protects users immediately without the regulatory complexity and access barriers of a licensed service model. Medical advocates often prefer the licensed model because it creates a clinical framework that builds toward insurance coverage and FDA approval. Both have real advantages for different populations and goals.
64 more replies — forum posting coming soon.
← Back to Legal & Policy